From June 11th to 13th, 2019, two auditors from the Korean Ministry of Food and Drug Safety, MFDS (hereinafter MFDS) conducted a three-day GMP audit of Zhejiang XinMingZhu Pharmaceutical Co., LTD. (hereinafter XMZ company). As an excellent long-time cooperation partner of XMZ, our company sent professional specialists to assist in the whole process.

This is the first MFDS audit of XMZ, to ensure the audit going smoothly, we carried out an overall in depth inspection of the target product two months before the MFDS comes, and developed a detailed protocol for the forthcoming audit by MFDS.

The two auditors conducted a comprehensive inspection of six systems, including quality management, production management and factory facilities and etc. All the related departments answered questions accurately and provided files in a timely manner which impressed the auditors deeply.

After three days of audit, and through the unremitting joint efforts of our company and XMZ. XMX company successfully passed the MFDS audit, and this laid a solid foundation for the market strategy of XMZ, at the same time reinforced our friendship and confidence to further expand the global market.